Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related AIG
AIG CEO On Bob Benmosche: The Company Wouldn't Have Survived Without Him
A Look At Dan Loeb's Diversified 13F
Tracking The Hotchkis & Wiley Value Opportunities Fund: Q4 2014 Update (Seeking Alpha)
Related FTEK
Top 4 NASDAQ Stocks In The Pollution & Treatment Controls Industry With The Highest Gross Margin
Fuel Tech Acquires Intellectual Property For ~$3.01M From CARBONITE Fuel Conversion Process,

Pre-open movers US stock futures are higher this morning, as investors are awaiting consumer credit data. Futures for the Dow Jones Industrial Average surged 33 points to 14,939.00 and S&P 500 index futures rose 2.10 points to 1,615.50. Nasdaq 100 futures gained 6 points to 2,953.50.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.35%, London's FTSE 100 index gained 0.46%, French CAC 40 Index gained 0.57% and German DAX 30 index rose 0.88%.

Asian markets ended higher, with Japan's Nikkei Stock Average jumping 3.55%, China's Shanghai Composite surging 0.20% and Australia's S&P/ASX 200 index dropping 0.22%. Hong Kong's Hang Seng Index rose 0.58% and India's Sensex gained 1.09%.

Broker Recommendation Analysts at Goldman Sachs downgraded American International Group (NYSE: AIG) from “buy” to “neutral.” The target price for American International Group is set to $46.

AIG's shares closed at $45.48 yesterday.

Breaking news

  • Fuel Tech (NASDAQ: FTEK) today announced it received three air pollution control contracts. To read the full news, click here.
  • Acacia Research Corporation (NASDAQ: ACTG) announced today that its Unified Messaging Solutions LLC subsidiary has entered into a license and settlement agreement with Capital One Financial (NYSE: COF) and Ing Direct. To read the full news, click here.
  • Dell (NASDAQ: DELL) today announced the acquisition of Enstratius, an award-winning enterprise cloud-management software and services provider that delivers single and multi-cloud management capabilities. To read the full news, click here.
  • Pluristem Therapeutics (NASDAQ: PSTI) announced today that it has identified its first clinical indication in the hematology field for its Placental eXpanded (PLX) RAD cells for the enhancement of the engraftment of Hematopoietic Stem Cells (HSC) in patients experiencing a delay or failure of their bone marrow transplant (BMT). To read the full news, click here.

Posted-In: Goldman Sachs US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (ACTG + AIG)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→